February 11, 2021
Seagen Reports Fourth Quarter and Full Year 2020 Financial Results
-Net Product Sales of $1 Billion in 2020, an Increase of 59 Percent Over 2019- -European Medicines Agency’s CHMP Adopted…
Pharmaceuticals, Biotechnology and Life Sciences
-Net Product Sales of $1 Billion in 2020, an Increase of 59 Percent Over 2019- -European Medicines Agency’s CHMP Adopted…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Infinity Pharmaceuticals, Inc. (Nasdaq: INFI) (“Infinity” or the “Company”), a clinical-stage biotechnology company developing eganelisib, an oral, immuno-oncology…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Infinity Pharmaceuticals, Inc. (Nasdaq: INFI) (“Infinity” or the “Company”), a clinical-stage biotechnology company developing eganelisib, an oral, immuno-oncology…
– Subgroup analysis of Phase 2 CHARMS study shows rapid resolution of macroscopic hematuria in patients with virus-associated hemorrhagic cystitis…
Head of Global Investment Opportunities Group of J.P. Morgan, Monica DiCenso, to address the state of the market and healthcare…
Head of Global Investment Opportunities Group of J.P. Morgan, Monica DiCenso, to address the state of the market and healthcare…
Head of Global Investment Opportunities Group of J.P. Morgan, Monica DiCenso, to address the state of the market and healthcare…
Head of Global Investment Opportunities Group of J.P. Morgan, Monica DiCenso, to address the state of the market and healthcare…
Head of Global Investment Opportunities Group of J.P. Morgan, Monica DiCenso, to address the state of the market and healthcare…
DUBLIN–(BUSINESS WIRE)–The “Asia Pacific Virus Filtration Market 2020-2026 by Product (Consumables, Instruments, Services), Application, End User, and Country: COVID-19 Impact…